Variant report
Variant | nsv521422 |
---|---|
Chromosome Location | chr4:171808256-171824549 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:16)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:16 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr4:171816014-171816270 | A549 | lung: | n/a | n/a |
2 | CEBPB | chr4:171816037-171816298 | K562 | blood: | n/a | n/a |
3 | CEBPB | chr4:171815988-171816327 | IMR90 | lung: | n/a | n/a |
4 | CEBPB | chr4:171816065-171816272 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | FOS | chr4:171810105-171810154 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOXA1 | chr4:171808574-171808906 | T-47D | breast: | n/a | chr4:171808730-171808745 |
7 | FOXA1 | chr4:171808559-171808922 | T-47D | breast: | n/a | chr4:171808730-171808745 |
8 | GATA3 | chr4:171820711-171820819 | SH-SY5Y | brain: | n/a | n/a |
9 | POLR2A | chr4:171816199-171816591 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | POLR2A | chr4:171815474-171815570 | ProgFib | skin: | n/a | n/a |
11 | POLR2A | chr4:171817334-171817471 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | POLR2A | chr4:171818445-171818645 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | POLR2A | chr4:171821435-171821508 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | POLR2A | chr4:171812284-171812420 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | STAT3 | chr4:171819236-171819332 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | ZNF143 | chr4:171814536-171814658 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNU6ATAC13P | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7695819 | chr4:171808256-171808257 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs369746626 | chr4:171808337-171808338 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs577325376 | chr4:171808359-171808360 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs150122822 | chr4:171808370-171808371 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538759566 | chr4:171808383-171808384 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs546367520 | chr4:171808439-171808440 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs559741029 | chr4:171808471-171808472 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs35040173 | chr4:171808486-171808487 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs573552616 | chr4:171808489-171808490 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537377201 | chr4:171808541-171808542 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs552109345 | chr4:171808563-171808564 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs560831925 | chr4:171808565-171808566 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs565535707 | chr4:171808579-171808580 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs529719328 | chr4:171808594-171808595 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs549571903 | chr4:171808621-171808622 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs563390245 | chr4:171808654-171808655 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs531223454 | chr4:171808676-171808677 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs532157835 | chr4:171808677-171808678 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs552328055 | chr4:171808682-171808683 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs557283761 | chr4:171808705-171808706 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs577155755 | chr4:171808718-171808719 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs151299078 | chr4:171808773-171808774 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs182202206 | chr4:171808844-171808845 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs139320223 | chr4:171808846-171808847 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs79672375 | chr4:171808854-171808855 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs557116698 | chr4:171808917-171808918 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs375935774 | chr4:171808942-171808943 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs200551673 | chr4:171808951-171808952 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs556983798 | chr4:171808952-171808953 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs752495 | chr4:171808969-171808970 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs539575123 | chr4:171809014-171809015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553513221 | chr4:171809035-171809036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs186762091 | chr4:171809049-171809050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs573490709 | chr4:171809079-171809080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs5864051 | chr4:171809115-171809116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs3048510 | chr4:171809116-171809117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs397836732 | chr4:171809118-171809119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs190831376 | chr4:171809187-171809188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs7669141 | chr4:171809238-171809239 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs546653937 | chr4:171809291-171809292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs77699702 | chr4:171809307-171809308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs534464862 | chr4:171809317-171809318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs543404668 | chr4:171809337-171809338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs33944832 | chr4:171809341-171809342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs386402258 | chr4:171809343-171809344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs371491204 | chr4:171809348-171809349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs370410975 | chr4:171809349-171809350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs76677344 | chr4:171809350-171809351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs183948513 | chr4:171809402-171809403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs532219278 | chr4:171809444-171809445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Developmental delay | 22127048 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:171793600-171809200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr4:171808000-171808800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr4:171808200-171808600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
4 | chr4:171808200-171808800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr4:171808200-171808800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr4:171808400-171809000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr4:171808600-171808800 | Enhancers | H1 Cell Line | embryonic stem cell |
8 | chr4:171809000-171813600 | Weak transcription | H1 Cell Line | embryonic stem cell |
9 | chr4:171813600-171814800 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
10 | chr4:171814400-171814600 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr4:171814400-171814800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr4:171823800-171824200 | Enhancers | Pancreas | Pancrea |